Calcineurin inhibitors and cardiac hypertrophy

被引：81

作者：

Luo, ZY

Shyu, KG

Gualberto, A

Walsh, K

机构：

[1] St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA

[2] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA

来源：

NATURE MEDICINE | 1998年 / 4卷 / 10期

关键词：

D O I：

10.1038/2578

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1092 / 1093

页数：2

共 7 条

[1]

Hasegawa K, 1997, CIRCULATION, V96, P3943

[2] LEFT-VENTRICULAR HYPERTROPHY IN CYCLOSPORINE-INDUCED SYSTEMIC HYPERTENSION AFTER CARDIAC TRANSPLANTATION [J].

MCKOY, RC ;

URETSKY, BF ;

KORMOS, R ;

HARDESTY, RL ;

GRIFFITH, BP ;

SALERNI, R .

AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (16) :1140-1142

[3] A calcineurin-dependent transcriptional pathway for cardiac hypertrophy [J].

Molkentin, JD ;

Lu, JR ;

Antos, CL ;

Markham, B ;

Richardson, J ;

Robbins, J ;

Grant, SR ;

Olson, EN .

CELL, 1998, 93 (02) :215-228

[4]

RADERMACHERJ, 1998, TRANSPL INT, V11, P3

[5] Transcription factors of the NFAT family: Regulation and function [J].

Rao, A ;

Luo, C ;

Hogan, PG .

ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :707-747

[6]

SADEGHI A M, 1987, Current Surgery, V44, P51

[7] Molecular and cellular biology of heart failure [J].

Schwartz, K ;

Mercadier, JJ .

CURRENT OPINION IN CARDIOLOGY, 1996, 11 (03) :227-236

← 1 →